ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 191 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2018. The put-call ratio across all filers is 1.26 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $1,081,000 | -30.0% | 41,577 | 0.0% | 0.04% | -34.5% |
Q3 2020 | $1,545,000 | -27.6% | 41,577 | 0.0% | 0.06% | -28.4% |
Q2 2020 | $2,133,000 | +62.7% | 41,577 | 0.0% | 0.08% | +37.3% |
Q1 2020 | $1,311,000 | -89.7% | 41,577 | -80.5% | 0.06% | -87.8% |
Q4 2019 | $12,735,000 | +62.7% | 213,562 | 0.0% | 0.48% | +40.9% |
Q3 2019 | $7,829,000 | -8.8% | 213,562 | +15.7% | 0.34% | -2.3% |
Q2 2019 | $8,588,000 | +15.9% | 184,607 | 0.0% | 0.35% | +16.3% |
Q1 2019 | $7,412,000 | +13.2% | 184,607 | +29.7% | 0.30% | +7.5% |
Q4 2018 | $6,545,000 | -22.1% | 142,289 | -24.8% | 0.28% | -8.2% |
Q3 2018 | $8,399,000 | +13.2% | 189,287 | 0.0% | 0.30% | +8.5% |
Q2 2018 | $7,418,000 | -45.8% | 189,287 | 0.0% | 0.28% | -47.2% |
Q1 2018 | $13,691,000 | +963.8% | 189,287 | +84.1% | 0.53% | +867.3% |
Q4 2016 | $1,287,000 | -9.6% | 102,800 | 0.0% | 0.06% | 0.0% |
Q3 2016 | $1,424,000 | +40.2% | 102,800 | 0.0% | 0.06% | +34.1% |
Q2 2016 | $1,016,000 | -41.5% | 102,800 | 0.0% | 0.04% | -44.6% |
Q1 2016 | $1,738,000 | -24.0% | 102,800 | 0.0% | 0.07% | -10.8% |
Q4 2015 | $2,288,000 | -52.8% | 102,800 | -50.0% | 0.08% | -52.3% |
Q3 2015 | $4,850,000 | -80.0% | 205,600 | -30.5% | 0.17% | -80.1% |
Q2 2015 | $24,200,000 | – | 296,000 | – | 0.88% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 2,629,835 | $116,685,000 | 25.08% |
Aviva Holdings Ltd. | 1,200,100 | $53,248,000 | 14.21% |
Boxer Capital, LLC | 1,375,000 | $61,009,000 | 6.77% |
BB BIOTECH AG | 3,282,964 | $145,665,000 | 3.86% |
Rhenman & Partners Asset Management AB | 353,961 | $15,705,000 | 1.57% |
PFM Health Sciences, LP | 1,970,134 | $87,415,000 | 1.28% |
Bellevue Group AG | 391,852 | $17,386,000 | 1.10% |
Pentwater Capital Management LP | 2,351,500 | $104,336,000 | 0.88% |
Partner Investment Management, L.P. | 25,440 | $1,129,000 | 0.86% |
SABBY MANAGEMENT, LLC | 100,369 | $4,453,000 | 0.57% |